An ongoing phase 3b4 safety trial of nivolumab (nivo) in patients (pts) with advanced or metastatic

来源 :第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 | 被引量 : 0次 | 上传用户：shijiatiedaoxueyuan

【摘要】

：

　　Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily

【作者】

：

Todd m.Bauer Michael Mccleod Jason c.Chandler George r.Blumenschein Lee s.Schwartzberg Howard Burris David Waterhouse Robert m.Jotte Maen Hussein David r.Spigel Dana s.Thompson Xuemei Li Craig h.Reyno

【机构】

：

SarahCannonResearchInstitute/TennesseeOncology,PLLCFloridaCancerSpecialistsTheWestClinicAndersonCanc

【出处】

：

第十八届全国临床肿瘤学大会暨2015年CSCO学术年会

【发表日期】

：

2015年9期

【关键词】

：

nivolumab NSCLC safety

下载到本地 , 更方便阅读

下载此文赞助VIP

声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架

论文部分内容阅读

　　Objective: Nivo, a fully human IgG4 programmed death-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily pretreated pts with advanced NSCLC.

其他文献

Fetal programming of the Adult Hypothalamic-Pituitary Adrenal (HPA) Axis

Background It has become clear that subtle changes in the intrauterine environment are important in determining the health and development of the fetus.

会议

用药安全和防范用药错误臺灣經驗分享

大綱了解醫療疏失發生的原因為何?(System Theory)探討如何有效防範醫療疏失?用藥安全監測錯誤防範機制就醫比搭飛機安全?每兩天,掉三架巨無霸客機的死亡人數在美國每年因醫

会议

复发性内异症的诊治

REM ●定义-内异症患者经手术或有规则药物治疗后,症状体征已消失,评价已治愈,但经过几个月(3个月)症状、体征重又出现●主要问题-疼痛,包块,不孕·发生率-6.1％-40％REM发病率·

会议

解读《阻塞性睡眠呼吸暂停与卒中诊治专家共识》

卒中是人类的第二位死因,在中国为首位死因.我国现存卒中患者超过700万,居血管性疾病之首[1-4].每年新发病例100万～200万,校正年龄后卒中年发病率为(116～219) /10万,年死亡率为

会议

The Predictive value of MGMT Promoter Methylation Status in Asian and Caucasian Patients with Malign

　　Objective: The prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter status for survival of patients with malignant gliomas rema

会议

MalignantGliomasTemozolomideMGMT

原发鼻腔副鼻窦黏膜恶性黑色素瘤52例放射治疗疗效分析

　　目的：鼻腔副鼻窦恶性黑色素瘤发病率低，预后差。鼻腔副鼻窦恶性黑色素瘤以手术治疗为主，放疗的报道较少，其作用仍有争议。本文回顾性分析原发鼻腔副鼻窦恶性黑色素瘤52例，探讨

会议

黏膜恶性黑色素瘤鼻腔副鼻窦手术放射治疗预后

Spreading Patterns of Lymph Nodes and the Role of Elective Neck Irradiation for Esthesioneuroblastom

　　Objective: Esthesioneuroblastoma (ENB) is a rare malignant neoplasm with great controversies on management of the neck.The aim of this study is to character

会议

EsthesioneuroblastomaLymphatic spreadingElective

ps-Tg10ngml的分化型甲状腺癌患者131I治疗后的临床转归

　　目的：探讨术后131I治疗前刺激性甲状腺球蛋白(ps-Tg)＜ 10ng/ml的非远处转移性分化型甲状腺癌(DTC)患者经131I治疗后的临床转归，以及ps-Tg对DTC患者临床转归的预测价值.方法：2

会议

分化型甲状腺癌甲状腺球蛋白131I治疗

Comprehensive genomic profiling of advanced cancers identifies MET exon 14 alterations that are sens

　　Objective: Amplifications and activating mutations in the c-MET proto-oncogene are known oncogenic drivers that have proven responsive to targeted therapy.

会议

metcrizotiniblung carcinoma

First-line monotherapy with nivolumab (nivo;anti-programmed death-1 [PD-1]) in advanced NSCLCsafety,

　　Objective: Nivo, a fully human IgG4 PD-1 immune checkpoint inhibitor antibody, has demonstrated durable responses and tolerability in heavily pretreated pat

会议

nivolumabNSCLCPD-L1

An ongoing phase 3b4 safety trial of nivolumab (nivo) in patients (pts) with advanced or metastatic

与本文相关的学术论文